Gould Capital »

Immunitybio shares owned by Gould Capital

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Gould Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $434 117 3.72

More positions owned by Gould Capital

Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Vanguard Total Bond Market Etf Etf (BND)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Total International Bond Etf Etf (BNDX)
Apple Stock (AAPL)
Spdr Gold Shares Etf (GLD)
Microsoft Corp Stock (MSFT)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Ishares Short Treasury Bond Etf Etf (SHV)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Public Storage Oper Reit (PSA)
Aflac Stock (AFL)
Bank New York Mellon Corp Stock (BK)
Aes Corp Stock (AES)
Coca Cola Stock (KO)

View all positions for Gould Capital

Top funds holding Immunitybio

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Geode Capital Management
Bank of America Corporation
Susquehanna International
Charles Schwab Investment Management
Cormorant Asset Management
Northern Trust
Jpmorgan Chase & Co
Goldman Sachs Group
Citadel Advisors
Jane Street
First Trust Advisors

View all funds holding Immunitybio